Cover Image

Review of rituximab in chop chemotherapy with chop only chemotherapy in treating aggressive Non Hodgkin's Lymphoma in elderly patients / Hazwan Ab Hamid

Background: The diffuse large B-cell lymphoma is a type of aggressive Non­ Hodgkin' s lymphoma (NHL) that is commonly found in elderly patients. CHOP chemotherapy has been used to treat this aggressive lymphoma. CHOP has brought several toxicities to patients especially to the elderly aggressiv...

Full description

Saved in:
Bibliographic Details
Main Author: Ab Hamid, Hazwan
Format: Thesis
Language:English
Published: 2013
Subjects:
Pharmacopoeias
Online Access:https://ir.uitm.edu.my/id/eprint/109522/1/109522.PDF
https://ir.uitm.edu.my/id/eprint/109522/
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.uitm.ir.109522
record_format eprints
spelling my.uitm.ir.1095222025-02-14T11:54:18Z https://ir.uitm.edu.my/id/eprint/109522/ Review of rituximab in chop chemotherapy with chop only chemotherapy in treating aggressive Non Hodgkin's Lymphoma in elderly patients / Hazwan Ab Hamid Ab Hamid, Hazwan Pharmacopoeias Background: The diffuse large B-cell lymphoma is a type of aggressive Non­ Hodgkin' s lymphoma (NHL) that is commonly found in elderly patients. CHOP chemotherapy has been used to treat this aggressive lymphoma. CHOP has brought several toxicities to patients especially to the elderly aggressive NHL patients. New combination of chemo drug, rituximab was introduce lately and brings an impact to the old CHOP chemotherapy. Its efficacy is known better from CHOP only regimen. Method: Journals containing articles that are relevant to the subject of efficacy of rituximab in CHOP chemotherapy are gathered and systematic review and analysis was done to extract the information. Results: Several articles supported the hypothesis and confirmed its efficacy compared to CHOP only chemotherapy. And its toxicity towards the elderly patients is relevant. Conclusion: Rituximab plus CHOP is proven better than CHOP only chemotherapy in the term of its efficacy. 2013 Thesis NonPeerReviewed text en https://ir.uitm.edu.my/id/eprint/109522/1/109522.PDF Review of rituximab in chop chemotherapy with chop only chemotherapy in treating aggressive Non Hodgkin's Lymphoma in elderly patients / Hazwan Ab Hamid. (2013) Degree thesis, thesis, Universiti Teknologi MARA (Kampus Puncak Alam).
institution Universiti Teknologi Mara
building Tun Abdul Razak Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Teknologi Mara
content_source UiTM Institutional Repository
url_provider http://ir.uitm.edu.my/
language English
topic Pharmacopoeias
spellingShingle Pharmacopoeias
Ab Hamid, Hazwan
Review of rituximab in chop chemotherapy with chop only chemotherapy in treating aggressive Non Hodgkin's Lymphoma in elderly patients / Hazwan Ab Hamid
description Background: The diffuse large B-cell lymphoma is a type of aggressive Non­ Hodgkin' s lymphoma (NHL) that is commonly found in elderly patients. CHOP chemotherapy has been used to treat this aggressive lymphoma. CHOP has brought several toxicities to patients especially to the elderly aggressive NHL patients. New combination of chemo drug, rituximab was introduce lately and brings an impact to the old CHOP chemotherapy. Its efficacy is known better from CHOP only regimen. Method: Journals containing articles that are relevant to the subject of efficacy of rituximab in CHOP chemotherapy are gathered and systematic review and analysis was done to extract the information. Results: Several articles supported the hypothesis and confirmed its efficacy compared to CHOP only chemotherapy. And its toxicity towards the elderly patients is relevant. Conclusion: Rituximab plus CHOP is proven better than CHOP only chemotherapy in the term of its efficacy.
format Thesis
author Ab Hamid, Hazwan
author_facet Ab Hamid, Hazwan
author_sort Ab Hamid, Hazwan
title Review of rituximab in chop chemotherapy with chop only chemotherapy in treating aggressive Non Hodgkin's Lymphoma in elderly patients / Hazwan Ab Hamid
title_short Review of rituximab in chop chemotherapy with chop only chemotherapy in treating aggressive Non Hodgkin's Lymphoma in elderly patients / Hazwan Ab Hamid
title_full Review of rituximab in chop chemotherapy with chop only chemotherapy in treating aggressive Non Hodgkin's Lymphoma in elderly patients / Hazwan Ab Hamid
title_fullStr Review of rituximab in chop chemotherapy with chop only chemotherapy in treating aggressive Non Hodgkin's Lymphoma in elderly patients / Hazwan Ab Hamid
title_full_unstemmed Review of rituximab in chop chemotherapy with chop only chemotherapy in treating aggressive Non Hodgkin's Lymphoma in elderly patients / Hazwan Ab Hamid
title_sort review of rituximab in chop chemotherapy with chop only chemotherapy in treating aggressive non hodgkin's lymphoma in elderly patients / hazwan ab hamid
publishDate 2013
url https://ir.uitm.edu.my/id/eprint/109522/1/109522.PDF
https://ir.uitm.edu.my/id/eprint/109522/
_version_ 1825165114353909760
score 13.239859

Similar Items